ONCOVIR, INC.

Basic Information

3203 CLEVELAND AVE NW
WASHINGTON, DC, 20008-3450

http://oncovir.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 167088330
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 5


  1. In-Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol (Poly-IC

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): Hiltonol (poly-ICLC) is a stabilized dsRNA therapeutic viral mimic or 'danger signal' that activates multiple elements of innate and adaptive immunity. ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Hiltonol provides potent neuroprotection from ischemic brain injury in stroke.

    Amount: $257,382.00

    DESCRIPTION (provided by applicant): Brain ischemia is a leading cause of morbidity and mortality in the United States. We seek to develop therapeutics to reduce the extent of damage and functional im ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government